ScripsAmerica Featured in SeeThruEquity's Monthly Newsletter
TYSONS CORNER, Va., Jan. 22, 2015 (GLOBE NEWSWIRE) -- ScripsAmerica, Inc. (OTCBB:SCRC) today announced that the Company is featured in the January 2015 monthly newsletter published by SeeThruEquity, a leading independent equity research and corporate access firm focused on smallcap and microcap public companies.
ScripsAmerica is featured on pages 5-6 of the SeeThruEquity Vol. 1 January 2015 edition. Some excerpts from the newsletter that management of the Company would like to highlight include the following: "ScripsAmerica seems to have shifted solidly into the black, with management guiding to robust growth and positive cash flow for results covering the second half of 2014. The key to the turnaround has been the strong performance of the company's specialty pharmacy business..."
The feature also mentioned several catalysts ahead for ScripsAmerica in 2015 as the Company expands its specialty pharmacy business and launches its RapiMed(R) children's pain reliever and fever reducer using oral delivery technology. SeeThruEquity initiated research coverage of ScripsAmerica in December 2014, setting a price target of $1.20 for the Company.
About SeeThruEquity
SeeThruEquity is an equity research and corporate access firm focused on publicly traded small and microcap companies. The company distributes its research, which is not paid for and unbiased, to its database of opt-in investors. SeeThruEquity is approved to contribute its research to Thomson Estimates, the leading estimates platform on Wall Street, in addition to Thomson One Analytics (First Call), Capital IQ, FactSet and Zacks. For more information visit www.seethruequity.com.
About ScripsAmerica, Inc.
ScripsAmerica, Inc. is a supplier of prescription, OTC and nutraceutical drugs, delivering pharmaceutical products to a wide range of end users across the health care industry. End users include retail pharmacies, hospitals, long-term care facilities and government and home care agencies. For more information, visit www.ScripsAmerica.com.
Safe Harbor Statement
This release includes forward-looking statements, which are based on certain assumptions and reflects management's current expectations. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results or events to differ materially from current expectations. Some of these factors include: general global economic conditions; general industry and market conditions, sector changes and growth rates; uncertainty as to whether our strategies and business plans will yield the expected benefits; increasing competition; availability and cost of capital; the ability to identify and develop and achieve commercial success; the level of expenditures necessary to maintain and improve the quality of services; changes in the economy; changes in laws and regulations, including codes and standards, intellectual property rights, and tax matters; or other matters not anticipated; our ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
CONTACT: Seal Point Consulting, LLC
888-959-7095
ir@sealpointconsulting.com
(MORE TO FOLLOW) Dow Jones Newswires
January 22, 2015 08:00 ET (13:00 GMT)
TYSONS CORNER, Va., Jan. 22, 2015 (GLOBE NEWSWIRE) -- ScripsAmerica, Inc. (OTCBB:SCRC) today announced that the Company is featured in the January 2015 monthly newsletter published by SeeThruEquity, a leading independent equity research and corporate access firm focused on smallcap and microcap public companies.
ScripsAmerica is featured on pages 5-6 of the SeeThruEquity Vol. 1 January 2015 edition. Some excerpts from the newsletter that management of the Company would like to highlight include the following: "ScripsAmerica seems to have shifted solidly into the black, with management guiding to robust growth and positive cash flow for results covering the second half of 2014. The key to the turnaround has been the strong performance of the company's specialty pharmacy business..."
The feature also mentioned several catalysts ahead for ScripsAmerica in 2015 as the Company expands its specialty pharmacy business and launches its RapiMed(R) children's pain reliever and fever reducer using oral delivery technology. SeeThruEquity initiated research coverage of ScripsAmerica in December 2014, setting a price target of $1.20 for the Company.
About SeeThruEquity
SeeThruEquity is an equity research and corporate access firm focused on publicly traded small and microcap companies. The company distributes its research, which is not paid for and unbiased, to its database of opt-in investors. SeeThruEquity is approved to contribute its research to Thomson Estimates, the leading estimates platform on Wall Street, in addition to Thomson One Analytics (First Call), Capital IQ, FactSet and Zacks. For more information visit www.seethruequity.com.
About ScripsAmerica, Inc.
ScripsAmerica, Inc. is a supplier of prescription, OTC and nutraceutical drugs, delivering pharmaceutical products to a wide range of end users across the health care industry. End users include retail pharmacies, hospitals, long-term care facilities and government and home care agencies. For more information, visit www.ScripsAmerica.com.
Safe Harbor Statement
This release includes forward-looking statements, which are based on certain assumptions and reflects management's current expectations. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results or events to differ materially from current expectations. Some of these factors include: general global economic conditions; general industry and market conditions, sector changes and growth rates; uncertainty as to whether our strategies and business plans will yield the expected benefits; increasing competition; availability and cost of capital; the ability to identify and develop and achieve commercial success; the level of expenditures necessary to maintain and improve the quality of services; changes in the economy; changes in laws and regulations, including codes and standards, intellectual property rights, and tax matters; or other matters not anticipated; our ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
CONTACT: Seal Point Consulting, LLC
888-959-7095
ir@sealpointconsulting.com
(MORE TO FOLLOW) Dow Jones Newswires
January 22, 2015 08:00 ET (13:00 GMT)
